Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness (DOMS)
Completed · Phase 3 · Has a placebo group
Conditions studied: Delayed Onset Muscle Soreness, DOMS
In brief
This is a Phase 3, prospective, randomized, dual-center, double-blind, placebo-controlled, parallel-group study designed to determine the efficacy and safety of SST-0225 (5.4 grams, applied up to 6 times in 24 hours, over a 48-hour dosing period) for the treatment of pain associated with DOMS.
Key facts
- Study ID
- NCT02597634
- Run by
- Strategic Science & Technologies, LLC
- People needed
- 156
- Starts
- 2015-11-01
- Expected to finish
- 2016-10-01
- Last updated by the study team
- 2016-10-13
Who can join
Age: 16 and older, up to 65. Sex: any. Healthy volunteers: accepted.
Where it is running
- Site #203 — Hollywood, Florida, United States
- Site #201 — South Miami, Florida, United States
- Site #202 — Springfield, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.